Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-17
2007-07-17
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S423000, C548S530000, C548S539000
Reexamination Certificate
active
10856921
ABSTRACT:
Compounds that are derivatives of 3-aminomethyl-pyrrolidine generally containing at least one benzhydril moiety are useful in treating conditions which benefit from blocking calcium ion channels.
REFERENCES:
patent: 5116851 (1992-05-01), Krapcho et al.
patent: 5386025 (1995-01-01), Jay et al.
patent: 5395832 (1995-03-01), Ito et al.
patent: 5428038 (1995-06-01), Chatterjee et al.
patent: 5623051 (1997-04-01), Catterall et al.
patent: 5646149 (1997-07-01), Hellberg et al.
patent: 5703071 (1997-12-01), Itoh et al.
patent: 6011035 (2000-01-01), Snutch et al.
patent: 6166037 (2000-12-01), Budhu et al.
patent: 6294533 (2001-09-01), Snutch et al.
patent: 6310059 (2001-10-01), Snutch
patent: 6387897 (2002-05-01), Snutch
patent: 0 640 601 (1995-03-01), None
patent: WO 92/22527 (1992-12-01), None
patent: WO 97/27180 (1997-07-01), None
patent: WO 99/09984 (1999-03-01), None
patent: WO 03/029199 (2003-04-01), None
Ito et al. 1993, CAS: 118:80825.
Cox and Denyer, Expert Opinion on Therapeutic Patents (1998) 8(10):1237-1250.
International Search Report for PCT/CA2004/000797, mailed on Aug. 30, 2004, 7 pages.
Valenta et al., Collection of Czechoslovak Chemical Communications (1994) 59(5):1126-1136.
Bourinet et al., Nature Neuroscience (1999) 2:407-415.
Cribbs et al., Circulation Research (1998) 83:103-109.
Dooley, Current Opinion in CPNS Investigational Drugs (1999) 1:116-125.
Dunlap et al., Trends Neurosci (1995) 18:89-98.
Gould et al., Proc. Natl. Acad. Sci. USA (1983) 80:5122-5125.
Grantham et al., Brit. J. Pharmacol. (1944) 111:483-488.
King et al., J. Biol. Chem. (1989) 264:5633-5641.
Lee et al., Journal of Neuroscience (1999) 19:1912-1921.
McCleskey et al., Curr. Topics. Membr. (1991) 39:295-326.
Perez-Reyes et al., Nature (1998) 391:896-900.
Sather et al., Nueron (1993) 11:291-303.
Stea et al., Proc. Natl. Acad. Sci. USA (1994) 91:10576-10580.
Ding Yanbing
Pajouhesh Hassan
Pajouhesh Hossein
Snutch Terrance P.
Morrison & Foerster / LLP
Neuromed Pharmaceuticals Ltd.
Saeed Kamal A.
Shiao Rei-tsang
LandOfFree
N-type calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-type calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-type calcium channel blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3732185